Skip to main content
BWIN
NASDAQ Finance

Baldwin Sets Jan. 6 Vote on $32.50/Share Sequence-DFO Take-Private

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Insurance Stocks · Financial
Sentiment info
Neutral
Importance info
8
Price
$32.15
Mkt Cap
$4.519B
52W Low
$15.88
52W High
$32.705
52W Position info
102% above low
Off High info
1.7% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

BWIN has more than doubled off its 52-week low of $15.88.

Summary

Baldwin filed the definitive proxy for its $32.50-per-share cash take-private by Sequence and DFO, setting a January 6, 2027 shareholder vote after the HSR waiting period expired November 4, 2026.


Key Events · M&A and Partnerships · BWIN

  • Special Meeting Set for January 6, 2027

    Shareholders of record on November 12, 2026 will vote on the merger agreement, an adjournment proposal and advisory golden parachute compensation; the board unanimously recommends approval.

  • $32.50 Cash Per Share Unchanged

    Each Class A share converts into $32.50 in cash, an 87.5% premium to the $17.33 unaffected close on June 17, 2026 and 9.6% above the $29.65 close on September 11, 2026.

  • HSR Waiting Period Expired November 4

    The 30-day HSR waiting period following the October 5, 2026 filings expired, leaving the shareholder vote and state insurance change-of-control approvals as the main remaining conditions.

  • $7.7 Billion Funding Package Committed

    DFO committed up to $4,599,000,000 of equity ($965 million senior plus $3,634 million common) alongside $2,750,000,000 of term loans, a $415,000,000 delayed draw facility and a $500,000,000 revolver; the deal has no financing condition.


Analysis · BWIN · Finance

The definitive proxy now puts the $32.50-per-share cash buyout in front of shareholders, with a special meeting set for January 6, 2027. Deal economics are unchanged from the September 14 announcement, but the document locks in the timeline and confirms the path is clear: the HSR waiting period expired November 4, 2026, leaving the shareholder vote as the only remaining major hurdle. It also quantifies what holders are being asked to approve: a $7.7 billion total funding package ($4.599 billion of DFO equity plus roughly $3.1 billion of debt), a $170.3 million break fee, and a $298.5 million capped TRA termination payment that the special committee negotiated to add $0.50 per share. With the stock at $32.15 against a $32.50 deal price, the market is pricing in a small but real chance the vote or remaining insurance approvals slip.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 48.3% of the 2133 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.28%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BWIN was trading at $32.15 on NASDAQ in the Finance sector, with a market capitalization of approximately $4.5B. The 52-week trading range was $15.88 to $32.71. This filing was assessed with neutral market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BWIN - Latest Insights

BWIN
Nov 09, 2026, 4:38 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $32.15
Real-time Price: $32.15 info
Change: $0 (0%) info
Market Cap: $4.519B info
BWIN
Nov 09, 2026, 4:08 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $32.15
Real-time Price: $32.15 info
Change: $0 (0%) info
Market Cap: $4.519B info
BWIN
Oct 27, 2026, 9:02 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $31.99
Real-time Price: $32.15 info
Change: +$0.160 (+0.50%) info
Market Cap: $4.519B info
BWIN
Oct 27, 2026, 9:01 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $31.99
Real-time Price: $32.15 info
Change: +$0.160 (+0.50%) info
Market Cap: $4.519B info
BWIN
Oct 15, 2026, 8:37 AM EDT
Filing Type: PREM14A
Importance Score:
8
Price at Filing: $31.97
Real-time Price: $32.15 info
Change: +$0.180 (+0.56%) info
Market Cap: $4.519B info